Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

HFRX Global Hedge Fund Index gained 1.12% (est) in October (+6.52% YTD)

Wednesday, November 03, 2010
Opalesque Industry Update - Equity Markets posted mixed results for the month of October, broadly maintaining but not building on September's strong gains, performance was generally stronger in Asian equity markets. Fixed income markets also gained in October in anticipation of additional quantitative easing & corresponding bond purchases in the US; investors also continued to focus on the mortgage markets and new developments related to foreclosure processing. The US dollar declined against both the Euro and the Yen, while commodities were also mixed, with strong gains in Sugar. The HFRX Global Hedge Fund Index gained +1.12% for the month, with strength in Relative Value Arbitrage, Macro and Equity Hedge offsetting weakness in Event Driven strategies.

The strongest area of contribution was from Relative Value Arbitrage strategies as the HFRX Relative Value Arbitrage Index posted a gain of +1.68%, bringing YTD performance of the index to +6.52%. Performance was strong across different sub-strategy indices as yields generally declined in anticipation of US government fixed income purchases. Both Convertible Arbitrage and RV: Multi-Strategy exposures contributed to gains, as high yield credit generally improved and volatility declined slightly.

Event Driven strategies were the weakest area of performance in an otherwise positive month, with the HFRX Event Driven Index posting a decline of -0.59%; this loss pares YTD gains to +1.42%. Gains in Distressed and Merger Arbitrage (+2.36 and +0.91, respectively) were offset by losses in equity-sensitive Special Situations exposures, as restructurings and announced transactions generally benefited from lower yields and steady improvements in investor risk tolerance. Special Situations posted on offsetting decline of -1.05% on selective weakness in US & developed market equities.

The HFRX Equity Hedge Index posted a gain of +1.55 in a mixed environment for global equity markets, bringing YTD gains to +3.39%. Equity Hedge has the strongest contributions from Fundamental Value and Equity Market Neutral, each adding +1.52 and +0.63%, respectively. Fundamental Growth strategies posted a narrow gain of +0.06% for the month.

Macro strategies posted a gain for the October, with the HFRX Macro Index adding +0.97%, paring a YTD decline in Macro to -1.95%. Macro gains were concentrated in Systematic strategies, which posted a gain of +1.89 on strength in long commodities and metals exposures. Discretionary strategies once again had a partially offsetting negative contribution.

(press release)

Source

kb

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for